| Authors: |
Guillem P; Department of Surgery, Clinique du Val d'Ouest, Ecully, France.; European Hidradenitis Suppurativa Foundation (EHSF), Dessau, Germany.; RésoVerneuil, Paris, France.; Groupe de Recherche en Proctologie de la Société Nationale Française de Coloproctologie (SNFCP), Paris, France., Sayed CJ; European Hidradenitis Suppurativa Foundation (EHSF), Dessau, Germany.; Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Goldberg SR; Mary Washington Healthcare, Fredericksburg, VA, USA., Muscianisi E; Novartis Gene Therapies, Bannockburn, IL, USA., Martinez AL; Novartis Pharma AG, Basel, Switzerland., Thomas N; Novartis Pharma AG, Basel, Switzerland., Alarcon I; Novartis Pharma AG, Basel, Switzerland., van der Zee HH; European Hidradenitis Suppurativa Foundation (EHSF), Dessau, Germany.; Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands., Bechara FG; International Center for Hidradenitis Suppurativa/Acne Inversa (ICH); Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany. |
